$11.10
+0.01 (+0.09%)
Open$11.30
Previous Close$11.09
Day High$11.40
Day Low$11.10
52W High$38.76
52W Low$22.58
Volume—
Avg Volume261.1K
Market Cap38.91M
P/E Ratio19.38
EPS$1.59
SectorBiotechnology
Analyst Ratings
Strong Buy
9 analysts
Price Target
+217.6% upside
Current
$11.10
$11.10
Target
$35.25
$35.25
$27.20
$35.25 avg
$53.45
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 6.98M | 7.00M | 7.72M |
| Net Income | -1,326,181 | -1,545,557 | -1,571,652 |
| Profit Margin | -19.0% | -22.1% | -20.4% |
| EBITDA | -1,878,590 | -1,945,549 | -2,406,257 |
| Free Cash Flow | -1,092,947 | -1,597,568 | -1,077,092 |
| Rev Growth | +10.9% | +1.3% | +2.5% |
| Debt/Equity | 0.21 | 0.18 | 0.23 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |